Position in ZTS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$216,087
+$2,571 QoQ
Shares Held
1,828
+7.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CATALYST FINANCIAL PARTNERS LLC holds $254,660 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
470 | $254,660 |
All Filings in ZTS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $216,087 | 1,828 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $213,516 | 1,697 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $306,833 | 2,097 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $341,998 | 2,193 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $377,048 | 2,290 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $380,278 | 2,334 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $439,018 | 2,247 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $376,017 | 2,169 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $312,023 | 1,844 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $404,016 | 2,047 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $338,565 | 1,946 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $292,757 | 1,700 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $273,627 | 1,644 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $222,169 | 1,516 | Shares | Sole | 2023-01-19 | |
| No filing history on record for this holder in this stock. | ||||||